Two-dimensional LC-MS/MS determination of antiretroviral drugs in rat serum and urine.

[1]  Thomas Le Saux,et al.  Quantification of seven nucleoside/nucleotide reverse transcriptase inhibitors in human plasma by high-performance liquid chromatography with tandem mass-spectrometry. , 2008, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[2]  G. di Perri,et al.  HPLC-MS method for the simultaneous quantification of the new HIV protease inhibitor darunavir, and 11 other antiretroviral agents in plasma of HIV-infected patients. , 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[3]  P. Solich,et al.  Using restricted-access materials and column switching in high-performance liquid chromatography for direct analysis of biologically-active compounds in complex matrices , 2007 .

[4]  M. Bartlett,et al.  Simultaneous determination of abacavir and zidovudine from rat tissues using HPLC with ultraviolet detection. , 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[5]  P. Bonnet,et al.  Determination of 19 antiretroviral agents in pharmaceuticals or suspected products with two methods using high-performance liquid chromatography. , 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[6]  H. Balfour,et al.  An isocratic liquid chromatography method for determining HIV non-nucleoside reverse transcriptase inhibitor and protease inhibitor concentrations in human plasma. , 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[7]  A. Kashuba,et al.  High-performance liquid chromatography assay for the determination of the HIV-protease inhibitor tipranavir in human plasma in combination with nine other antiretroviral medications. , 2007, Journal of pharmaceutical and biomedical analysis.

[8]  A. Telenti,et al.  Determination of the novel non-peptidic HIV-protease inhibitor tipranavir by HPLC-UV after solid-phase extraction. , 2006, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[9]  P. Narciso,et al.  Simultaneous determination of 16 anti-HIV drugs in human plasma by high-performance liquid chromatography. , 2006, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[10]  B. Gazzard,et al.  Comparison of first-line antiretroviral therapy with regimens including nevirapine, efavirenz, or both drugs, plus stavudine and lamivudine: a randomised open-label trial, the 2NN Study , 2004, The Lancet.

[11]  J. Ravitch,et al.  High-performance liquid chromatographic assay for abacavir and its two major metabolites in human urine and cerebrospinal fluid. , 2001, Journal of chromatography. B, Biomedical sciences and applications.

[12]  B. Diquet,et al.  Determination of twelve antiretroviral agents in human plasma sample using reversed-phase high-performance liquid chromatography. , 2000, Journal of chromatography. B, Biomedical sciences and applications.

[13]  P. Sinko,et al.  Oral absorption of the HIV protease inhibitors: a current update. , 1999, Advanced drug delivery reviews.

[14]  R. Yogev,et al.  Safety and Single-Dose Pharmacokinetics of Abacavir (1592U89) in Human Immunodeficiency Virus Type 1-Infected Children , 1999, Antimicrobial Agents and Chemotherapy.

[15]  E A Emini,et al.  Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy. , 1997, The New England journal of medicine.

[16]  D. Westerlund,et al.  Influence of mobile phase conditions on the clean-up effect of restricted-access media precolumns for plasma samples injected in a column-switching system , 1997 .

[17]  L. Boone,et al.  1592U89, a novel carbocyclic nucleoside analog with potent, selective anti-human immunodeficiency virus activity , 1997, Antimicrobial agents and chemotherapy.

[18]  K. Boos,et al.  The use of restricted-access media in HPLC, Part I ― Classification and review , 1997 .

[19]  B. Feibush,et al.  Shielded hydrophobic phase: a new concept for direct injection analysis of biological fluids by high-performance liquid chromatography. , 1988, Journal of chromatography.

[20]  R. Zahradník,et al.  Weak intermolecular interactions in chemistry and biology , 1980 .